Matches in SemOpenAlex for { <https://semopenalex.org/work/W3026748185> ?p ?o ?g. }
Showing items 1 to 65 of
65
with 100 items per page.
- W3026748185 abstract "Research Aim: The vascular endothelial growth factors secreted by tumors play an important role in vascular permeability and tumor angiogenesis through binding to their receptors on the surface of the endothelial cells. In this study, an antagonist peptide of vascular endothelial growth factor (VEGF) was designed, interfering in the binding of VEGFA and VEGFB to VEGFR1 and VEGFR2, to block the signaling pathways in downstream of both the receptors whereby angiogenesis and tumor growth are inhibited.Research method: To confirm the binding of the designed peptide (VGB4) to VEGFR1 and VEGFR2, the flow cytometry and immunofluorescence microscopy assay were carried out. In order to examine the anti-angiogenic activity of VGB4 peptide, endothelial cell proliferation, migration, and angiogenesis tests were performed on HUVECs. Likewise, using 4T1 mammary carcinoma cell line, as a murine breast cancer model in BALB/c mice, VGB4 delivery potential to tumor was evaluated via in vivo imaging. Then,Anti-tumor potential of different doses of VGB4 was examined by intraperitoneal injection to 4T1 breast tumor-bearing mice.The level of angiogenesis, proliferation and apoptosis markers in VGB4 treated tumors was assessed by immunohistochemistry analysis. For the evaluation of the key signaling molecules as well as metastasis markers in down stream pathways of VEGFR1 and VEGFR2, western blot analysis was used. The effect of VGB4 on the expression level of migration and invasion markers in tumor cells was examined using real time PCR. Findings: VGB4 peptide had the binding ability to both VEGFR1 and VEGFR2 and significantly inhibited endothelial cell proliferation, migration, and angiogenesis. The accumulation potential of VGB4 in tumor tissue was confirmed. In addition, the results of in vivo study revealed that VGB4 administration dose-dependently led to an effective decrease in tumor growth as well as angiogenesis and an increase in apoptosis. Likewise, VGB4 significantly inactivated the signaling pathways related to both VEGFR1 and VEGFR2 in vitro and in vivo. The anti-metastatic potential of VGB4 was also verifiedin 4T1 breast tumor samples.Conclusion: Given the significant antagonistic effects of VGB4 on the suppression of angiogenesis and tumor growth, this peptide can be considered as a suitable candidate for cancer therapy." @default.
- W3026748185 created "2020-05-29" @default.
- W3026748185 creator A5013366523 @default.
- W3026748185 creator A5030750456 @default.
- W3026748185 creator A5071168309 @default.
- W3026748185 creator A5079656581 @default.
- W3026748185 date "2018-01-01" @default.
- W3026748185 modified "2023-09-23" @default.
- W3026748185 title "The effect of vascular endothelial growth factor antagonist peptide on endothelial cells and the inhibition of angiogenesis in breast tumor" @default.
- W3026748185 hasPublicationYear "2018" @default.
- W3026748185 type Work @default.
- W3026748185 sameAs 3026748185 @default.
- W3026748185 citedByCount "0" @default.
- W3026748185 crossrefType "dissertation" @default.
- W3026748185 hasAuthorship W3026748185A5013366523 @default.
- W3026748185 hasAuthorship W3026748185A5030750456 @default.
- W3026748185 hasAuthorship W3026748185A5071168309 @default.
- W3026748185 hasAuthorship W3026748185A5079656581 @default.
- W3026748185 hasConcept C123012128 @default.
- W3026748185 hasConcept C146285616 @default.
- W3026748185 hasConcept C14858245 @default.
- W3026748185 hasConcept C167734588 @default.
- W3026748185 hasConcept C202751555 @default.
- W3026748185 hasConcept C2777025900 @default.
- W3026748185 hasConcept C2780394083 @default.
- W3026748185 hasConcept C502942594 @default.
- W3026748185 hasConcept C55493867 @default.
- W3026748185 hasConcept C86803240 @default.
- W3026748185 hasConceptScore W3026748185C123012128 @default.
- W3026748185 hasConceptScore W3026748185C146285616 @default.
- W3026748185 hasConceptScore W3026748185C14858245 @default.
- W3026748185 hasConceptScore W3026748185C167734588 @default.
- W3026748185 hasConceptScore W3026748185C202751555 @default.
- W3026748185 hasConceptScore W3026748185C2777025900 @default.
- W3026748185 hasConceptScore W3026748185C2780394083 @default.
- W3026748185 hasConceptScore W3026748185C502942594 @default.
- W3026748185 hasConceptScore W3026748185C55493867 @default.
- W3026748185 hasConceptScore W3026748185C86803240 @default.
- W3026748185 hasLocation W30267481851 @default.
- W3026748185 hasOpenAccess W3026748185 @default.
- W3026748185 hasPrimaryLocation W30267481851 @default.
- W3026748185 hasRelatedWork W1826592847 @default.
- W3026748185 hasRelatedWork W1964187194 @default.
- W3026748185 hasRelatedWork W2010468452 @default.
- W3026748185 hasRelatedWork W2032892351 @default.
- W3026748185 hasRelatedWork W2033157617 @default.
- W3026748185 hasRelatedWork W2053214209 @default.
- W3026748185 hasRelatedWork W2102772371 @default.
- W3026748185 hasRelatedWork W2118634694 @default.
- W3026748185 hasRelatedWork W2163038297 @default.
- W3026748185 hasRelatedWork W2304044561 @default.
- W3026748185 hasRelatedWork W2326087726 @default.
- W3026748185 hasRelatedWork W2561598730 @default.
- W3026748185 hasRelatedWork W2601475443 @default.
- W3026748185 hasRelatedWork W2754482101 @default.
- W3026748185 hasRelatedWork W2763108561 @default.
- W3026748185 hasRelatedWork W2765307116 @default.
- W3026748185 hasRelatedWork W2769024706 @default.
- W3026748185 hasRelatedWork W3008680920 @default.
- W3026748185 hasRelatedWork W3041541768 @default.
- W3026748185 hasRelatedWork W3199010652 @default.
- W3026748185 isParatext "false" @default.
- W3026748185 isRetracted "false" @default.
- W3026748185 magId "3026748185" @default.
- W3026748185 workType "dissertation" @default.